Sight OLO CBC Test Kit, Model/Catalog Number: TK1. A disposable cartridge and sample preparation ...

FDA Device Recall #Z-2173-2024 — Class II — May 13, 2024

Recall Summary

Recall Number Z-2173-2024
Classification Class II — Moderate risk
Date Initiated May 13, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm SIGHT DIAGNOSTICS LTD
Location Tel Aviv-Yafo
Product Type Devices
Quantity 7,450 units (2,800 US, 4,650 OUS)

Product Description

Sight OLO CBC Test Kit, Model/Catalog Number: TK1. A disposable cartridge and sample preparation tools for use with the Sight OLO CBC analyzer.

Reason for Recall

One Test Kit lot (TK1-10114) shows a positive bias in the platelet count due to bacterial contamination which can result in elevated counts with a bias of 7.5 k/ul. This results in the test kit lot performing outside of the device specification.

Distribution Pattern

Worldwide - US Nationwide distribution in the states of AL, FL, MS, TX, WI and the countries of Canada, Israel, Slovenia, Trinidad & Tobago.

Lot / Code Information

REF: TK1, UDI-DI: B787TK10, Lot Code: 10114

Other Recalls from SIGHT DIAGNOSTICS LTD

Recall # Classification Product Date
Z-1469-2022 Class II Sight OLO, Automated Hematology Analyzer, Catal... Jun 14, 2022
Z-0963-2022 Class II The Sight OLO device is a computer vision based... Jan 20, 2022
Z-2517-2021 Class II Sight OLO-E1/U1 Software and Operators Manual ... Mar 17, 2021

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.